Vitalis Pharmaceutical Co., Ltd. | Soins de la Peau / Produits Quasi-médicamenteuxOEM/ODM Manufacturing (Saitama)

À Propos de la Fabrication OEM de Vitalis Pharmaceutical Co., Ltd.

A pharmaceutical company founded in 1935. The company develops products across four categories: pharmaceuticals, cosmetics, health foods, and alcoholic beverages. Leveraging production expertise cultivated over its long history, the company has recently focused on OEM/ODM operations. Its strengths include small-lot production that large companies find difficult to accommodate, and formula development based on attentive client consultations.

Activités Commerciales de Vitalis Pharmaceutical Co., Ltd.

• Vitalis Pharmaceutical Co.
• Ltd. engages in the manufacturing and sales of pharmaceutical and quasi-pharmaceutical products
• as well as the import and export of these items. The company also manufactures and distributes cosmetics and health food products domestically and internationally. Additionally
• Vitalis Pharmaceutical handles the production and distribution of alcoholic beverages and soft drinks
• medical and hygiene devices
• and daily necessities
• along with their import and export operations. The company provides OEM and ODM formulation development services
• contract manufacturing
• raw material wholesale distribution
• and agency business operations.

Caractéristiques & Points Forts de Vitalis Pharmaceutical Co., Ltd.

• Pharmaceutical-company-grade quality management
• Small-lot capability

Certifications & Équipements de Vitalis Pharmaceutical Co., Ltd.

Implantations de Vitalis Pharmaceutical Co., Ltd.

Historique de l'Entreprise Vitalis Pharmaceutical Co., Ltd.

• —

  Vitalis Pharmaceutical Co., Ltd. was established in April 1935. In June 1938, the company opened its Tokyo Sales Office in Shibuya Ward and constructed the No. 2 Factory. The No. 3 Factory was built in Funabashi, Chiba Prefecture in March 1940. In January 1955, the company obtained a pharmaceutical manufacturing license and launched Neo-Orthol. Cosmetics manufacturing commenced in April 1960, followed by the launch of Aurora skincare products in May 1961. The male external hormone ointment Ottopin was released in October 1962. OEM manufacturing operations began in June 1984, and a manufacturing patent for Calopeptide was obtained in November 1986. In January 2000, the company changed its name from Ottoseal Pharmaceutical to Pro-Seal Co., Ltd., and merged with Ecopack Co., Ltd. in July 2000. A new manufacturing patent for Calopeptide was acquired in March 2001. The company reverted to the name Vitalis Pharmaceutical in March 2006. In March 2018, the agency business operations commenced, and BPO services began in January 2023.

Récompenses et Reconnaissances de Vitalis Pharmaceutical Co., Ltd.

• Calopeptide Manufacturing Patent (1986)
• New Manufacturing Patent (2001)

Catégories Supportées par Vitalis Pharmaceutical Co., Ltd.

FAQ sur Vitalis Pharmaceutical Co., Ltd.